Marotrao 2018.
Study name | Randomized trial on use of intravenous immunoglobulin in young patients with recent onset dilated cardiomyopathy |
Methods | Randomised, parallel‐group trial |
Participants | Patients < 25 years of age with dilated cardiomyopathy with left ventricular dysfunction and recent onset of symptoms (duration < 6 months) |
Interventions | 2 g/kg intravenous immunoglobulin over 3 days |
Outcomes | Improvement in left ventricular end‐diastolic dimension at 6 months; event‐free survival (i.e. death, hospitalisation, and transplant‐free survival) at 6 months |
Starting date | 2018 |
Contact information | patilsuraj762@gmail.com |
Notes |